Catalent Inc (NYSE:CTLT)

116.86
Delayed Data
As of Jan 22
 -1.42 / -1.20%
Today’s Change
31.04
Today|||52-Week Range
120.48
+12.29%
Year-to-Date
What Are Moderna's Risks?
6:10am / MotleyFool.com - Paid Partner Content
Why Catalent (CTLT) is Poised to Beat Earnings Estimates Again
Jan 18 / Zacks.com - Paid Partner Content
Ayala Pharmaceuticals (AYLA) Soars: Stock Adds 13.2% in Session
Jan 20 / Zacks.com - Paid Partner Content
Acorda (ACOR) Soars on Sale of Manufacturing Unit for Inbrija
Jan 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close118.28
Today’s open117.88
Day’s range116.08 - 118.49
Volume914,773
Average volume (3 months)1,457,902
Market cap$19.2B
Data as of 4:00pm ET, 01/22/2021

Growth & Valuation

Earnings growth (last year)+26.20%
Earnings growth (this year)+22.02%
Earnings growth (next 5 years)+18.34%
Revenue growth (last year)+22.89%
P/E ratio73.0
Price/Sales3.61
Price/Book6.56

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+5.59+3.35%
HZNPHorizon Therapeutics...+0.29+0.37%
INCYIncyte Corp+3.98+4.24%
VTRSViatris Inc+0.12+0.69%
Data as of 4:00pm ET, 01/22/2021

Financials

Next reporting dateFebruary 2, 2021
EPS forecast (this quarter)$0.55
Annual revenue (last year)$3.1B
Annual profit (last year)$173.0M
Net profit margin5.59%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Somerset, New Jersey

Forecasts